Similar companies
| Company | Est. Net Value | |
|---|---|---|
 |
Encompass HealthEHC |
$8,000 |
Are Members of Congress Buying or Selling Tenet Healthcare?
No members of Congress have reported trading Tenet Healthcare (THC) stock in the past 90 days. The history below covers the past two years.
Congressional trading is one of the alternative data signals AltIndex tracks as part of the THC AI Score. For corporate insider activity, see THC insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.
Which Congress Members Are Trading Tenet Healthcare?
| Member of Congress | Activity | Trades | Last Trade |
|---|---|---|---|
| Jonathan Jackson | Mixed $82,000 | 4 | Apr 20, 2026 |
| Lisa McClain | Bought $8,000 | 1 | Jun 11, 2025 |
THC Congressional Trade History
| Member of Congress | Trade Date | Type | Estimated Size |
|---|---|---|---|
| Jonathan Jackson | Apr 20, 2026 | Sell | $15K – $50K |
| Jonathan Jackson | Feb 11, 2026 | Sell | $1K – $15K |
| Jonathan Jackson | Dec 10, 2025 | Buy | $15K – $50K |
| Jonathan Jackson | Sep 3, 2025 | Buy | $1K – $15K |
| Lisa McClain | Jun 11, 2025 | Buy | $1K – $15K |
Frequently Asked Questions: Tenet Healthcare Congress Trading
No members of Congress have reported buying or selling THC stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.
Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.
Jonathan Jackson sold Tenet Healthcare (THC) stock most recently, on April 20, 2026.
The estimated net value of congressional trades in Tenet Healthcare over the past 2 years is positive, at $8,000, meaning members of Congress have on balance bought more than they have sold.
Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.
